Dynavax Technologies Corp (DVAX)

10.75
0.16 1.50
NASDAQ : Health Care
Prev Close 10.91
Open 10.89
Day Low/High 10.67 / 11.06
52 Wk Low/High 12.84 / 32.49
Volume 922.93K
Avg Volume 1.24M
Exchange NASDAQ
Shares Outstanding 38.50M
Market Cap 425.78M
EPS -3.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week

Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week

The risks of a September interest rate hike are now too great to be ignored, Cramer says.

4 Biotechs Set to Provide a Shot in the Arm

4 Biotechs Set to Provide a Shot in the Arm

Each company has approaching catalysts.

4 Biotechs Set to Provide a Shot in the Arm

4 Biotechs Set to Provide a Shot in the Arm

Each company has approaching catalysts.

Here's a Reason Why Dynavax Technologies (DVAX) Stock Is Soaring Today

Here's a Reason Why Dynavax Technologies (DVAX) Stock Is Soaring Today

William Blair said on Tuesday that the FDA's decision to cancel a November advisory meeting for Dynavax Technologies' (DVAX) hepatitis B vaccine could be beneficial to the company.

How to Play It When the FDA Slams Your Stock

How to Play It When the FDA Slams Your Stock

Here are three recent examples of how the patient can profit.

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Dynavax Technologies Corporation - DVAX

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Dynavax Technologies Corporation - DVAX

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Dynavax Technologies Corporation (NASDAQ:DVAX) resulting from allegations that...

Dynavax Technologies Corp is Now Oversold

Dynavax Technologies Corp is Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Dynavax Technologies (DVAX) Stock Plummets on Cancelled FDA Meeting

Dynavax Technologies (DVAX) Stock Plummets on Cancelled FDA Meeting

The FDA cancelled a meeting on Friday with Dynavax Technologies (DVAX) scheduled for November.

DVAX: Insiders vs. Shorts

DVAX: Insiders vs. Shorts

The most recent short interest data was recently released for the 07/29/2016 settlement date, and Dynavax Technologies Corp is one of the most shorted stocks of the Russell 3000, based on 13.81 "days to cover" versus the median component at 6.42. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

DVAX April 2017 Options Begin Trading

DVAX April 2017 Options Begin Trading

Investors in Dynavax Technologies Corp saw new options become available today, for the April 2017 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 242 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

5 Breakout Stocks to Buy for Big Gains

5 Breakout Stocks to Buy for Big Gains

These stocks are within range of triggering big breakouts. Here's how to trade them from here.

5 Small-Cap Biotechs With Big Potential

5 Small-Cap Biotechs With Big Potential

These 5 stocks all have positive catalysts on the horizon.

5 Small-Cap Biotechs With Big Potential

5 Small-Cap Biotechs With Big Potential

These 5 stocks all have positive catalysts on the horizon.

Will Insiders Be Tempted To Buy More DVAX At The New 52-Week Low?

Will Insiders Be Tempted To Buy More DVAX At The New 52-Week Low?

In trading on Monday, shares of Dynavax Technologies Corp touched a new 52-week low of $13.04/share. That's a $19.45 share price drop, or -59.86% decline from the 52-week high of $32.49 set back on 09/14/2015.

Commit To Purchase Dynavax Technologies Corp At $12, Earn 35.7% Annualized Using Options

Commit To Purchase Dynavax Technologies Corp At $12, Earn 35.7% Annualized Using Options

Investors considering a purchase of Dynavax Technologies Corp stock, but cautious about paying the going market price of $14.81/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2017 put at the $12 strike, which has a bid at the time of this writing of $2.50.

DVAX: Insiders Vs. Shorts

DVAX: Insiders Vs. Shorts

The most recent short interest data was recently released for the 03/31/2016 settlement date, and Dynavax Technologies Corp is one of the most shorted stocks of the Russell 3000, based on 7.84 "days to cover" versus the median component at 5.75. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Perilous Reversal Stock: Dynavax Technologies (DVAX)

Perilous Reversal Stock: Dynavax Technologies (DVAX)

Trade-Ideas LLC identified Dynavax Technologies (DVAX) as a "perilous reversal" (up big yesterday but down big today) candidate

Dynavax Technologies Enters Oversold Territory (DVAX)

Dynavax Technologies Enters Oversold Territory (DVAX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Today's Pre-Market Mover With Heavy Volume: Dynavax Technologies (DVAX)

Today's Pre-Market Mover With Heavy Volume: Dynavax Technologies (DVAX)

Trade-Ideas LLC identified Dynavax Technologies (DVAX) as a pre-market mover with heavy volume candidate

Strong On High Volume: Dynavax Technologies (DVAX)

Strong On High Volume: Dynavax Technologies (DVAX)

Trade-Ideas LLC identified Dynavax Technologies (DVAX) as a strong on high relative volume candidate

M&A Could Ignite Next Leg Up for Biotech

Pharma and biotech giants now must look to small- and mid-caps to fill out pipelines and bolster growth.

'Mad Money' Lightning Round: Take Lockheed Martin Over Boeing

'Mad Money' Lightning Round: Take Lockheed Martin Over Boeing

Cramer is not crazy about J.C. Penney and he's not buying AK Steel.

Jim Cramer's 'Mad Money' Recap: Be Brave, Keep Investing in Stocks

Jim Cramer's 'Mad Money' Recap: Be Brave, Keep Investing in Stocks

Don't let the talk of bubbles in the stock market scare you, Cramer says. The market is still the best game in town.

Here's Why Dynavax Technologies (DVAX) Stock is Climbing Today

Here's Why Dynavax Technologies (DVAX) Stock is Climbing Today

Dynavax Technologies (DVAX) stock is rising as the FDA accepted for review the company's vaccine candidate for immunization against hepatitis B infection in adults 18 years and up.

Revisiting 3 Promising Small Biotechs

They are oversold and lately been on the move.

Interesting DVAX Put And Call Options For May 20th

Interesting DVAX Put And Call Options For May 20th

Investors in Dynavax Technologies Corp saw new options begin trading this week, for the May 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DVAX options chain for the new May 20th contracts and identified one put and one call contract of particular interest.

A Small Biotech Sells for Less Than Cash

And yet, Endocyte has a deep pipeline.